Novartis AG - Company Profile
Powered by 
All the data and insights you need on Novartis AG in one report.
$295
- Save hours of research time and resources with
our up-to-date Novartis AG Strategy Report
- Understand Novartis AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreNovartis AG Clinical Trials
Determine Novartis AG go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Novartis AG Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer | GDCT0474783 | 68Ga-PSMA-11; lutetium Lu 177 vipivotide tetraxetan | Oncology | Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer | Phase II | Planned | Novartis AG |
| Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) (VAYHIT1) | GDCT0474593 | ianalumab | Hematological Disorders | Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) | Phase III | Planned | Novartis AG |
| Efficacy and Safety of Inclisiran as Monotherapy in Patients with Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy | GDCT0474559 | inclisiran | Metabolic Disorders | Hypercholesterolemia | Phase III | Ongoing, recruiting | Novartis AG |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward